Literature DB >> 21412508

Anticoagulation in renal failure is safe and effective.

Reinhard Klingel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412508      PMCID: PMC3057620          DOI: 10.3238/arztebl.2011.0112a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

Review 1.  Drug therapy in patients with chronic renal failure.

Authors:  Bertram Hartmann; David Czock; Frieder Keller
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

2.  Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.

Authors:  Antonella Bisio; Davide Vecchietti; Laura Citterio; Marco Guerrini; Rahul Raman; Sabrina Bertini; Giorgio Eisele; Annamaria Naggi; Ram Sasisekharan; Giangiacomo Torri
Journal:  Thromb Haemost       Date:  2009-11       Impact factor: 5.249

3.  Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events.

Authors:  Jean-Philippe Collet; Gilles Montalescot; Giancarlo Agnelli; Frans Van de Werf; Enrique P Gurfinkel; Jose López-Sendón; Christopher V Laufenberg; Martin Klutman; Neelam Gowda; Dietrich Gulba
Journal:  Eur Heart J       Date:  2005-06-02       Impact factor: 29.983

4.  Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.

Authors:  Sarah A Spinler; Stephanie M Inverso; Marc Cohen; Shaun G Goodman; Kathleen A Stringer; Elliott M Antman
Journal:  Am Heart J       Date:  2003-07       Impact factor: 4.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.